Research Professor Akseli Hemminki presents on the Advanced Therapy Access Program
Research Professor Akseli Hemminki presents the latest data on safety and efficacy of oncolytic viruses and especially CGTG-102 in breast cancer, based on the Advanced Therapy Access Program by Oncos Therapeutics. The presentation takes place in IIR’s Breast Cancer 2010 conference in Helsinki, Finland, on May 5, 2010.
CGTG-102 oncolytic virus in breast cancer (IIR Conference May 5, 2010)
View more presentations from Oncos Therapeutics.
Following the event, Research Professor Akseli Hemminki also held a public presentation “The promise of gene therapy and oncolytic viruses” on May 25, 2010. The presentation includes descriptions for mode of action, and data on efficacy and safety.
